1
|
Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.
|
Annu Rev Physiol
|
2008
|
3.20
|
2
|
In vivo effects of a GPR30 antagonist.
|
Nat Chem Biol
|
2009
|
2.39
|
3
|
GPR30 predicts poor survival for ovarian cancer.
|
Gynecol Oncol
|
2009
|
1.63
|
4
|
Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity.
|
J Steroid Biochem Mol Biol
|
2011
|
1.42
|
5
|
Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles.
|
Cancer Res
|
2009
|
1.17
|
6
|
Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30.
|
J Med Chem
|
2010
|
1.16
|
7
|
Characterization of magnetite nanoparticles for SQUID-relaxometry and magnetic needle biopsy.
|
J Magn Magn Mater
|
2009
|
1.14
|
8
|
Characterization of single-core magnetite nanoparticles for magnetic imaging by SQUID relaxometry.
|
Phys Med Biol
|
2010
|
1.06
|
9
|
GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state.
|
Endocrinology
|
2013
|
1.03
|
10
|
Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction.
|
Hypertension
|
2011
|
0.97
|
11
|
Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI.
|
Contrast Media Mol Imaging
|
2012
|
0.96
|
12
|
Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells.
|
Breast Cancer Res Treat
|
2010
|
0.87
|
13
|
Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers.
|
J Nucl Med
|
2008
|
0.86
|
14
|
Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents.
|
ACS Chem Biol
|
2010
|
0.81
|
15
|
Microenvironmental control of the breast cancer cell cycle.
|
Anat Rec (Hoboken)
|
2012
|
0.80
|
16
|
Development of antibody-tagged nanoparticles for detection of transplant rejection using biomagnetic sensors.
|
Cell Transplant
|
2012
|
0.76
|
17
|
Magnetic relaxometry as applied to sensitive cancer detection and localization.
|
Biomed Tech (Berl)
|
2015
|
0.75
|